Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency
- PMID: 315432
Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency
Similar articles
-
Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate.J Immunol. 1979 Dec;123(6):2870-7. J Immunol. 1979. PMID: 315433
-
Studies of the induction and expression of T cell mediated immunity. VI. Heterogeneity of lytic efficiency exhibited by isolated cytotoxic T lymphocytes prepared from highly enriched populations of effector-target conjugates.J Immunol. 1977 Sep;119(3):1041-7. J Immunol. 1977. PMID: 302269 No abstract available.
-
Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.J Immunol. 1979 Aug;123(2):801-7. J Immunol. 1979. PMID: 156764 No abstract available.
-
Mechanism of specific tumor-cell lysis by alloimmune T lymphocytes: resolution and characterization of discrete steps in the cellular interaction.Contemp Top Immunobiol. 1977;7:301-61. doi: 10.1007/978-1-4684-3054-7_9. Contemp Top Immunobiol. 1977. PMID: 407049 Review. No abstract available.
-
T-Cell-mediated cytolysis: an overview of some current issues.Contemp Top Immunobiol. 1977;7:245-72. doi: 10.1007/978-1-4684-3054-7_7. Contemp Top Immunobiol. 1977. PMID: 195769 Review. No abstract available.
Cited by
-
Natural killer cells and autoimmunity.Immunol Res. 1989;8(4):292-304. doi: 10.1007/BF02935514. Immunol Res. 1989. PMID: 2687403 Review.
-
Application of a new method for detecting the phenotype of target binding cells.Cancer Immunol Immunother. 1987;25(2):153-5. doi: 10.1007/BF00199957. Cancer Immunol Immunother. 1987. PMID: 3311361 Free PMC article.
-
Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient.J Clin Immunol. 1992 May;12(3):210-5. doi: 10.1007/BF00918091. J Clin Immunol. 1992. PMID: 1400902
-
Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.J Clin Invest. 1989 Jan;83(1):278-87. doi: 10.1172/JCI113870. J Clin Invest. 1989. PMID: 2463268 Free PMC article.
-
Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy.Clin Exp Immunol. 1992 Jun;88(3):376-82. doi: 10.1111/j.1365-2249.1992.tb06457.x. Clin Exp Immunol. 1992. PMID: 1535035 Free PMC article.